Description
SODIUM FLUORIDE
First action · last action
2017-12-07 · 2020-03-26
Transactions
3
First transaction's obligation
$147,100
Base + all options value (sum of deltas)
$121,890
Extent competed
NOT COMPETED
Other than full & open authority
ONLY ONE SOURCE-OTHER (FAR 6.302-1 OTHER)
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING
Modification chain · 3 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2017-12-07+$147,100= $147,100
- Mod P000012017-12-08+$4,050= $151,150
- Mod P000022020-03-26-$29,260= $121,890
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2017-12-07 | +$147,100 | $147,100 | SODIUM FLUORIDE |
| Mod P00001· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2017-12-08 | +$4,050 | $151,150 | SODIUM FLUORIDE |
| Mod P00002· CLOSE OUT | 2020-03-26 | −$29,260 | $121,890 | SODIUM FLUORIDE |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI MKESZ56EH4Q1)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C26326N0517 | NETWORK CONTRACT OFFICE 23 (36C263) · 6505 · DRUGS AND BIOLOGICALS | $87,320 | FY2026 |
| 36C26326D0053 | NETWORK CONTRACT OFFICE 23 (36C263) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2026 |
| 36C26326N0294 | NETWORK CONTRACT OFFICE 23 (36C263) · 6505 · DRUGS AND BIOLOGICALS | $180,000 | FY2026 |
| 36C26326D0026 | NETWORK CONTRACT OFFICE 23 (36C263) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2026 |
| 36C25226N0042 | 252-NETWORK CONTRACT OFFICE 12 (36C252) · 6505 · DRUGS AND BIOLOGICALS | $186,763 | FY2026 |
| 36C25225D0055 | 252-NETWORK CONTRACT OFFICE 12 (36C252) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2025 |
Other recipients under 6505 from NETWORK CONTRACT OFFICE 23 (36C263) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C26326F0080 | MEDI-PHYSICS, INC. | NETWORK CONTRACT OFFICE 23 (36C263) | $27,788 | FY2026 |
| 36C26326P0460 | PROFOUNDA INC | NETWORK CONTRACT OFFICE 23 (36C263) | $49,950 | FY2026 |
| 36C26326N0416 | CARDINAL HEALTH 414, LLC | NETWORK CONTRACT OFFICE 23 (36C263) | $761,773 | FY2026 |
| 36C26326N0324 | SANFORD MEDICAL CENTER | NETWORK CONTRACT OFFICE 23 (36C263) | $111,919 | FY2026 |
| 36C26326D0032 | SANFORD MEDICAL CENTER | NETWORK CONTRACT OFFICE 23 (36C263) | $0 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C26318P0084_3600_-NONE-_-NONE- · retrieved 2026-09-26.